Autoimmune myositis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
H Endocrinology (ATC H) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
Corticosteroid 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Horizon Therapeutics Ireland Designated Activity Company Commercial
    DAXDILIMAB; PREDNISONE
    2022-502810-10-00 5 countries 2023 n=26
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Horizon Therapeutics Ireland Designated Activity Company Commercial 1 Phase II 0
New trials by year
2023
1
← All indication landscapes